Skyharbour’s Partner Company North Shore Uranium Commences Drill Program at Falcon Uranium Property
Vancouver, BC, March 08, 2024 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the […]
KULR Technology Receives Acceptance of Compliance Plan by NYSE American
SAN DIEGO, March 08, 2024 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a […]
Inuvo to Present at the iAccess Alpha Buyside Best Ideas Spring Conference 2024 on March 12
LITTLE ROCK, Ark., March 08, 2024 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of advertising technology, […]
EV Nickel Announces Pro-rata Participation by Strategic Investor and Upsize to Private Placement
Not for distribution to U.S. news wire services or dissemination in the United States TORONTO, March 08, 2024 (GLOBE NEWSWIRE) […]
Telos Corporation to Participate in 36th Annual Roth Conference on March 17-19, 2024
ASHBURN, Va., March 08, 2024 (GLOBE NEWSWIRE) — Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise […]
Apollo Names Chris McIntyre Global Head of the Institutional Client Group
NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) — Apollo Global Management, Inc. (NYSE: APO) today announced the appointment of Chris […]
Applied Digital Provides Update on Anchor Tenant at Ellendale HPC Facility
DALLAS, March 08, 2024 (GLOBE NEWSWIRE) — Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”), a designer, builder, […]
America’s Car-Mart Reports Third Quarter Fiscal 2024 Results
ROGERS, Ark., March 08, 2024 (GLOBE NEWSWIRE) — America’s Car-Mart, Inc. (NASDAQ: CRMT) (“we,” “Car-Mart” or the “Company”), today reported […]
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
Two pivotal Phase 3 clinical trials studying soticlestat as a treatment for Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS) completed […]
Ocuphire Pharma Announces Financial Results for Fourth Quarter and Full Year 2023 and Provides Corporate Update
FARMINGTON HILLS, Mich., March 08, 2024 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company focused on […]
